4 results on '"Verschuuren, Eric A. M."'
Search Results
2. Ervaringen met gecombineerde hart-longtransplantatie in het Universitair Medisch Centrum Groningen
- Author
-
Johan Brügemann, Wim van der Bij, Verschuuren, Eric A. M., Klungel, Aafke A., Horst, Iwan C. C., Michiel Erasmus, Huib Kerstjens, Dirk Jan van Veldhuisen, Felix Zijlstra, Critical care, Anesthesiology, Peri-operative and Emergency medicine, Cardiovasculair Centrum, Groningen Research Institute for Asthma and COPD, and Groningen Institute for Organ Transplantation
- Subjects
Adult ,Heart Diseases/complications ,Male ,Heart-Lung Transplantation/mortality ,Waiting Lists ,Middle Aged ,Postoperative Complications/mortality ,Hypertension, Pulmonary/complications ,Survival Rate ,Young Adult ,Cystic Fibrosis/complications ,Cause of Death ,Humans ,Female ,Cachexia/complications ,Immunosuppressive Agents/administration & dosage ,Netherlands ,Retrospective Studies - Abstract
OBJECTIVE: Reporting the results of combined heart-lung transplantation in the University Medical Center Groningen (UMCG), the Netherlands. DESIGN: Retrospective study. METHOD: Data were retrieved of patients who underwent a combined heart-lung transplantation in the UMCG between December 1996 and December 2007. Demographic, clinical and other relevant characteristics were recorded, as well as post-transplantation morbidity and mortality. RESULTS: The study group consisted of 14 patients (3 men and 11 women) with a mean age of 41 years. Indications for heart-lung transplantation were: congenital heart disease complicated by pulmonary hypertension (6 patients), idiopathic pulmonary hypertension with severe right ventricle failure (4 patients), lung fibrosis with severe right ventricle failure (1 patient), cystic fibrosis with systolic left ventricle failure (1 patient), pulmonary hypertension after thoracic radiation and chemotherapy (1 patient) and re-transplantation after lung-transplant failure (1 patient). The mean waiting time prior to operation was approximately 1.5 years. 9 of the 14 patients (64%) underwent such a marked clinical deterioration during the waiting period that they were given a 'very high urgency status' for transplantation. Almost half of patients became dependent on supplementary intravenous inotropics during the waiting period. At the end of the study 6 of the 14 patients (43%) were alive, with a mean survival period of 58 months (range: 6-132). Infection was the cause of death in 4 of the 8 patients. Of the 8 deceased patients, 4 were underweight preoperatively (BMI < 18.5 kg/m2) and were cachectic. This was the case in only 1 of the 6 surviving patients. CONCLUSION: A combined heart-lung transplantation is a rare operation in the Netherlands. The waiting time in this study was long and the post-transplantation mortality was high. Underweight (cachexia), a sign of a poor clinical condition, appears to be associated with mortality.
3. [Experiences of combined heart-lung transplantations in the University Medical Center Groningen].
- Author
-
Brügemann J, van der Bij W, Verschuuren EA, Klungel AA, van der Horst IC, Erasmus ME, Kerstjens HA, van Veldhuisen DJ, and Zijlstra F
- Subjects
- Adult, Cause of Death, Cystic Fibrosis complications, Cystic Fibrosis therapy, Female, Heart Diseases complications, Heart Diseases therapy, Humans, Hypertension, Pulmonary complications, Hypertension, Pulmonary therapy, Immunosuppressive Agents administration & dosage, Male, Middle Aged, Netherlands, Retrospective Studies, Survival Rate, Waiting Lists, Young Adult, Cachexia complications, Heart-Lung Transplantation mortality, Postoperative Complications mortality
- Abstract
Objective: Reporting the results of combined heart-lung transplantation in the University Medical Center Groningen (UMCG), the Netherlands., Design: Retrospective study., Method: Data were retrieved of patients who underwent a combined heart-lung transplantation in the UMCG between December 1996 and December 2007. Demographic, clinical and other relevant characteristics were recorded, as well as post-transplantation morbidity and mortality., Results: The study group consisted of 14 patients (3 men and 11 women) with a mean age of 41 years. Indications for heart-lung transplantation were: congenital heart disease complicated by pulmonary hypertension (6 patients), idiopathic pulmonary hypertension with severe right ventricle failure (4 patients), lung fibrosis with severe right ventricle failure (1 patient), cystic fibrosis with systolic left ventricle failure (1 patient), pulmonary hypertension after thoracic radiation and chemotherapy (1 patient) and re-transplantation after lung-transplant failure (1 patient). The mean waiting time prior to operation was approximately 1.5 years. 9 of the 14 patients (64%) underwent such a marked clinical deterioration during the waiting period that they were given a 'very high urgency status' for transplantation. Almost half of patients became dependent on supplementary intravenous inotropics during the waiting period. At the end of the study 6 of the 14 patients (43%) were alive, with a mean survival period of 58 months (range: 6-132). Infection was the cause of death in 4 of the 8 patients. Of the 8 deceased patients, 4 were underweight preoperatively (BMI < 18.5 kg/m2) and were cachectic. This was the case in only 1 of the 6 surviving patients., Conclusion: A combined heart-lung transplantation is a rare operation in the Netherlands. The waiting time in this study was long and the post-transplantation mortality was high. Underweight (cachexia), a sign of a poor clinical condition, appears to be associated with mortality.
- Published
- 2009
4. Extradural thoracic spinal cord compression: unusual initial presentation of post-transplant lymphoproliferative disorder.
- Author
-
Bakker NA, van Dijk JM, Slart RH, Coppes MH, van Imhoff GW, and Verschuuren EA
- Subjects
- Adult, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Cyclophosphamide administration & dosage, Doxorubicin administration & dosage, Emphysema etiology, Humans, Magnetic Resonance Imaging, Male, Prednisone administration & dosage, Radionuclide Imaging, Spinal Cord pathology, Spinal Cord Compression diagnosis, Spinal Cord Compression pathology, Thoracic Neoplasms diagnostic imaging, Thoracic Neoplasms drug therapy, Treatment Outcome, Vincristine administration & dosage, Emphysema surgery, Lung Transplantation adverse effects, Lymphoproliferative Disorders diagnosis, Postoperative Complications diagnosis, Spinal Cord Compression etiology, alpha 1-Antitrypsin Deficiency complications
- Abstract
Post-transplant lymphoproliferative disorder (PTLD) is a serious complication after solid-organ transplantation. We report a lung transplant recipient presenting with lower limb weakness as a result of extradural cord compression from PTLD. Diagnosis was made by laminectomy of T-3 with partial removal of the epidural mass. Further treatment consisted of chemoradiotherapy. The patient recovered completely. To our knowledge, this is the first reported case of PTLD presenting with signs and symptoms of spinal cord compression. The differential diagnosis of spinal cord compression in a patient who has had a transplant should include primary presentation of PTLD.
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.